What is bioAffinity Technologies?
bioAffinity Technologies is a company operating within the biotechnology sector, focused on developing innovative solutions. While specific details of its proprietary technology are not provided, its consistent pursuit of capital, including debt financing and equity placements, suggests a company in a scaling phase. The company's engagement with various funding mechanisms points towards a strategic approach to resource acquisition, likely to fuel research and development, market penetration, and operational scaling. The recent major strategic investment signals confidence from its backers in its long-term potential and market positioning.
How much funding has bioAffinity Technologies raised?
bioAffinity Technologies has raised a total of $13.3M across 6 funding rounds:
Series A
$4M
Debt
$150K
Debt
$5M
Debt
$212K
Share Placement
$2.5M
Share Placement
$1.4M
Series A (2017): $4M, investors not publicly disclosed
Debt (2020): $150K led by PPP
Debt (2020): $5M supported by Undisclosed
Debt (2021): $212K featuring PPP
Share Placement (2024): $2.5M backed by WallachBeth Capital
Share Placement (2025): $1.4M, investors not publicly disclosed
Key Investors in bioAffinity Technologies
WallachBeth Capital
WallachBeth Capital is a provider of institutional execution services, specializing in unconflicted advice and intelligent trading solutions for institutional investors. Their focus on capital markets support suggests an interest in companies with strong growth potential.
What's next for bioAffinity Technologies?
With the recent influx of major strategic investment, bioAffinity Technologies is poised for accelerated growth and development. The enterprise-level funding context suggests the company is likely focusing on expanding its market reach, enhancing its product pipeline, or scaling its operational capacity. Future strategic moves may involve further R&D initiatives, potential partnerships, or market expansion efforts. The company's trajectory indicates a commitment to innovation and a strategic vision for solidifying its position within the competitive biotechnology landscape.
See full bioAffinity Technologies company page
